Healthpeak Properties vs Keurig Dr Pepper
Side-by-side comparison of AI visibility scores, market position, and capabilities
Denver healthcare REIT (NYSE: DOC) $21B combined; Healthpeak + Physicians Realty Trust merger Mar 2024, life science labs (SF/SD/Boston) + 300+ MOBs, competing with Alexandria Real Estate and Ventas.
About
Healthpeak Properties, Inc. is a Denver, Colorado-based healthcare real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: DOC) as an S&P 500 Real Estate component — owning, operating, and developing healthcare-focused real estate including life science laboratory buildings (biopharmaceutical R&D facilities in South San Francisco, San Diego, Boston), medical office buildings (outpatient care facilities adjacent to major hospital campuses), and continuing care retirement communities through approximately 400 employees. In March 2024, Healthpeak Properties (then trading as HCP/PEAK) completed its $21 billion merger of equals with Physicians Realty Trust (DOC — medical office REIT with 300+ medical outpatient buildings in 30+ states) — adopting Physicians Realty Trust's ticker symbol "DOC" and creating a $21 billion combined healthcare REIT with 60+ million square feet of life science labs, 18+ million square feet of medical office, and the most diversified healthcare real estate portfolio among public healthcare REITs. CEO Scott Brinker leads the combined company's strategy of capitalizing on the structural demand drivers for healthcare real estate: life science lab demand driven by NIH funding, private biopharma venture investment, and drug approval tailwinds — and medical office demand driven by the shift of healthcare delivery from hospital inpatient settings to outpatient ambulatory care facilities that require real estate closer to patient populations. Healthpeak's life science portfolio in the three dominant biotech clusters (San Francisco Bay Area, San Diego's Torrey Pines/UTC corridor, Boston's Kendall Square/Route 128 corridor) positions it in the markets where biopharma and biotech tenants require Class A laboratory space for drug discovery and development.
Burlington MA beverages (NASDAQ: KDP) at $15.35B FY2024 revenue (+3.6%); Dr Pepper/7UP/Snapple + Keurig K-Cup, 82% FCF growth, 2025 guidance mid-single-digit growth competing with Coca-Cola and PepsiCo.
About
Keurig Dr Pepper Inc. is a Burlington, Massachusetts-based beverage company — publicly traded on NASDAQ (NASDAQ: KDP) as an S&P 500 Consumer Staples component — manufacturing, marketing, and distributing hot beverages (coffee through the Keurig single-serve system and Green Mountain roasted coffee brands), cold beverages (Dr Pepper, 7UP, Snapple, Canada Dry, A&W, Sunkist, Bai, Core, Clamato, Mott's, Hawaiian Punch, Penafiel), and producing/selling the Keurig K-Cup system (over 500 varieties of licensed K-Cup pods from 75+ coffee brands) through approximately 27,000 employees. In fiscal year 2024, Keurig Dr Pepper reported revenue of $15.35 billion (+3.6% year-over-year), adjusted diluted EPS growth of 8%, operating cash flow growth of 67% to $2.2 billion, and free cash flow growth of 82% to $1.7 billion. For 2025, KDP guided mid-single-digit net sales growth and high-single-digit adjusted EPS growth, reflecting continued volume growth in both the cold beverages portfolio and Keurig brewer and pod sales recovery. CEO Tim Cofer, who joined from Mondelez International in 2023, has prioritized revenue management (balancing price and volume), operational efficiency, and brand investment across KDP's portfolio of over 125 owned, licensed, and partner brands. Keurig Dr Pepper was formed through the 2018 merger of Keurig Green Mountain (coffee systems) and Dr Pepper Snapple Group (beverages), controlled by JAB Holding Company (a Luxembourg-based holding company of the Reimann family).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.